Metabolic Immune Restraints: Implications for Anticancer Vaccines

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|3|277-291

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.3, 2010-01, pp. : 277-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines

By Cadogan Martin   Dalgleish Angus G  

Clinical Medicine, Vol. 8, Iss. 3, 2008-06 ,pp. : 267-271

Royal College Of Physicians

Access to resources Recommend Favorite

Innovations and strategies for the development of anticancer vaccines

By Chamberlain R.S.   Kaufman H.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 603-614

Informa Healthcare

Access to resources Recommend Favorite

Prospects for the Therapeutic Use of Anticancer Vaccines

By Chamberlain R.S.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite

The Mucosal Immune Response to Plant-Derived Vaccines

By Hefferon Kathleen  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2040-2042

Springer Publishing Company

Access to resources Recommend Favorite

Synthetic Vaccines: The Role of Adjuvants in Immune Targeting

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1423-1439

Bentham Science Publishers

Access to resources Recommend Favorite